Contract facts
UnrestrictedNo full NAICS 541720 intel page yet. Browse NAICS intelligence
P00002 - Revising Deliverables Within the Sow ----Leveraging Real-World Data (RWD) to Investigate the Natural History o… is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC. Estimated value $2.9M ($2.9M obligated). Current period of performance ends Sep 29, 2028. Last award drew 1 bidder. Place of performance: IRVING TX. Related solicitation FDABAA-23-00123.
P00002 - revising deliverables within the sow ----leveraging real-world data (rwd) to investigate the natural history of rare cancers treated in the us community oncology setting to provide clinical context to inform future research. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Sep 29, 2028 (713 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 29, 2027.
Want the durability read on 75F40123C00199? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordMckesson Specialty Health Pharmaceutical & Biotech Solutions LLC — $16.5M obligated across 111 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40123C00199?
75F40123C00199 (RWD p00002 - revising deliverables) is a Fda Office Of Acq Grant Svcs award with a potential value of $2.9M, currently held by Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40123C00199?
Fda Office Of Acq Grant Svcs awarded 75F40123C00199 to Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC (potential $2.9M).
Who is the incumbent on 75F40123C00199?
Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC is the incumbent with $16.5M across 111 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2028.
When does Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC’s 75F40123C00199 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75F40123C00199? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.